HC Wainwright Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price

Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) had its price objective increased by HC Wainwright from $66.00 to $72.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other equities analysts have also issued reports on MIRM. Citigroup upped their price target on Mirum Pharmaceuticals from $65.00 […]

Leave a Reply

Your email address will not be published.

Previous post Q3 EPS Forecast for TransMedics Group Boosted by Analyst
Next post These high-growth careers stand out in job market